Quick Takeaways
- BTAI - BioXcel Therapeutics, Inc. has 33 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 33 Insiders of BioXcel Therapeutics, Inc.
- Symbol
- BTAI on Nasdaq
- Location
- New Haven, CT
What Changed
- No meaningful buy/sell imbalance is currently visible in the one-year window.
- Activity will update as new Forms 3/4/5 are filed.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsInsider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 29 Apr 2025.
Buys
$0
Shares: 0
Insiders: 0
Sells
$0
Shares: 0
Insiders: 0
Net
$0
Shares: 0
Insiders: 0
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
BioXcel Therapeutics, Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Vipin Agarwal | 10%+ Owner | $187,267,747 | Mixed | 03 Apr 2023 | ||
| Rashmi Agarwal | 10%+ Owner | $187,267,747 | Mixed | 03 Apr 2023 | ||
| Indu R. Gupta | 10%+ Owner | $187,168,169 | Mixed | 03 Apr 2023 | ||
| Tarun K. Gupta | 10%+ Owner | $187,168,169 | Mixed | 03 Apr 2023 | ||
| Suganthi Balasubramanian | 10%+ Owner | $187,110,248 | Mixed | 03 Apr 2023 | ||
| Anita Jain | 10%+ Owner | $187,100,398 | Mixed | 03 Apr 2023 | ||
| Diwakar Jain | 10%+ Owner | $187,100,398 | Mixed | 03 Apr 2023 | ||
| BioXcel LLC | 10%+ Owner | $187,088,358 | Mixed | 25 Jun 2021 | ||
| Anesha Agarwal | 10%+ Owner | $187,088,358 | Mixed | 03 Apr 2023 | ||
| Krunal Dilip Patel | 10%+ Owner | $187,088,358 | Mixed | 03 Apr 2023 | ||
| Alka Sood | 10%+ Owner | $187,088,358 | Mixed | 03 Apr 2023 | ||
| Pardeep Kumar Sood | 10%+ Owner | $187,088,358 | Mixed | 03 Apr 2023 | ||
| Michael James Aiello | 10%+ Owner | $187,088,358 | Mixed | 03 Apr 2023 | ||
| Marshal D. Gibson | 10%+ Owner | $187,088,358 | Mixed | 03 Apr 2023 | ||
| Krishnan Nandabalan | Director, 10%+ Owner | $187,088,358 | Mixed | 06 Apr 2023 | ||
| BioXcel Holdings, Inc. | 10%+ Owner | $187,088,358 | Mixed | 25 Jun 2021 | ||
| Akrati Agarwal | 10%+ Owner | $187,088,358 | Mixed | 03 Apr 2023 | ||
| Bina Jatin Patel | 10%+ Owner | $187,088,358 | Mixed | 03 Apr 2023 | ||
| Jatin Markand Patel | 10%+ Owner | $187,088,358 | Mixed | 03 Apr 2023 | ||
| Ph.D. Vimal Mehta | CEO and President, Director | $773,506 | Mixed | 14 Mar 2026 | ||
| David J. Mack | Director | $56,212 | Mixed | 09 Jan 2026 | ||
| Matthew T. Wiley | Chief Commercial Officer | $20,056 | Mixed | 17 Sep 2024 | ||
| Javier Rodriguez | Chief Legal Officer, Senior Vice President and Corporate Secretary | $10,705 | Mixed | 14 Mar 2026 | ||
| Richard I. Steinhart | Chief Financial Officer | $10,369 | Mixed | 14 Mar 2026 | ||
| Ph.D Frank Yocca | Chief Scientific Officer | $10,176 | Mixed | 14 Mar 2026 | ||
| Vincent O'Neill | Executive Vice President, Chief of Product Development and Medical Officer | $7,975 | Mixed | 14 Dec 2024 | ||
| Sandeep Laumas | Director | Mixed | 09 Jan 2026 | |||
| Michal Votruba | Director | Mixed | 09 Jan 2026 | |||
| Peter Mueller | Director | Mixed | 09 Jan 2026 | |||
| Michael Patrick Miller | Director | Mixed | 09 Jan 2026 | |||
| Rajiv Patni | Director | Mixed | 09 Jan 2026 | |||
| William P. Kane Jr. | Chief Commercial Officer | Mixed | 16 Aug 2021 | |||
| June Bray | Director | Mixed | 09 Jan 2026 |
Top shareholders of BioXcel Therapeutics, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Rashmi Agarwal |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,554,945
|
$187,267,747 | — | 03 Apr 2023 | |
| Vipin Agarwal |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,554,945
|
$187,267,747 | — | 03 Apr 2023 | |
| Indu R. Gupta |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,550,396
|
$187,168,169 | — | 03 Apr 2023 | |
| Tarun K. Gupta |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,550,396
|
$187,168,169 | — | 03 Apr 2023 | |
| Suganthi Balasubramanian |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,547,750
|
$187,110,248 | — | 03 Apr 2023 | |
| Anita Jain |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,547,300
|
$187,100,398 | — | 03 Apr 2023 | |
| Diwakar Jain |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,547,300
|
$187,100,398 | — | 03 Apr 2023 | |
| Krishnan Nandabalan |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
8,840,750
mixed-class rows
|
$187,088,358 | — | 06 Apr 2023 | |
| Akrati Agarwal |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 03 Apr 2023 | |
| Alka Sood |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 03 Apr 2023 | |
| Anesha Agarwal |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 03 Apr 2023 | |
| Bina Jatin Patel |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 03 Apr 2023 | |
| BioXcel Holdings, Inc. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 25 Jun 2021 | |
| BioXcel LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 25 Jun 2021 | |
| Jatin Markand Patel |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 03 Apr 2023 | |
| Krunal Dilip Patel |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 03 Apr 2023 | |
| Marshal D. Gibson |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 03 Apr 2023 | |
| Michael James Aiello |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 03 Apr 2023 | |
| Pardeep Kumar Sood |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 03 Apr 2023 | |
| INTEGRATED CORE STRATEGIES (US) LLC |
13D/G
|
Millennium Management LLC |
8.4%
|
1,835,192
|
$3,762,144 | +$1,654,635 | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
8.4%
|
1,835,192
|
$2,936,307 | — | 31 Dec 2025 | |
| Ph.D. Vimal Mehta |
3/4/5
|
CEO and President, Director |
—
mixed-class rows
|
503,259
mixed-class rows
|
$773,506 | — | 14 Mar 2026 | |
| ARMISTICE CAPITAL, LLC |
13D/G
|
— |
5%
|
288,131
|
$564,737 | -$9,229,922 | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.3%
|
292,753
|
$468,405 | — | 31 Dec 2025 | |
| OAKTREE CAPITAL MANAGEMENT LP |
13F
|
Company |
1.1%
|
241,188
|
$385,902 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.94%
|
206,168
|
$329,873 | — | 31 Dec 2025 | |
| JONES FINANCIAL COMPANIES LLLP |
13F
|
Company |
0.63%
|
137,690
|
$220,304 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.58%
|
127,501
|
$204,002 | — | 31 Dec 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.55%
|
120,102
|
$192,000 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
0.41%
|
90,300
|
$144,480 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.39%
|
84,396
|
$135,033 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.29%
|
63,218
|
$101,149 | — | 31 Dec 2025 | |
| Man Group plc |
13F
|
Company |
0.26%
|
56,825
|
$90,920 | — | 31 Dec 2025 | |
| Oaktree Fund Advisors, LLC |
13F
|
Company |
0.2%
|
42,913
|
$68,660 | — | 31 Dec 2025 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.19%
|
41,000
|
$65,600 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.18%
|
38,370
|
$61,392 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.18%
|
38,340
|
$61,344 | — | 31 Dec 2025 | |
| David J. Mack |
3/4/5
|
Director |
—
mixed-class rows
|
37,317
mixed-class rows
|
$56,212 | — | 09 Jan 2026 | |
| DIVERSIFY WEALTH MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
15,000
|
$30,750 | — | 31 Dec 2025 | |
| Oaktree Capital Group Holdings GP, LLC |
13D/G
|
Oaktree Capital Holdings, LLC |
2.7%
|
170,230
|
$28,939 | -$434,154 | 31 Mar 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.08%
|
18,062
|
$28,000 | — | 31 Dec 2025 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.08%
|
17,068
|
$27,309 | — | 31 Dec 2025 | |
| Qatar Investment Authority |
13D/G
|
— |
0.6%
|
156,066
|
$26,531 | -$436,562 | 31 Dec 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.07%
|
15,749
|
$25,197 | — | 31 Dec 2025 | |
| Matthew T. Wiley |
3/4/5
|
Chief Commercial Officer |
—
mixed-class rows
|
28,386
mixed-class rows
|
$20,056 | — | 17 Sep 2024 | |
| Engineers Gate Manager LP |
13F
|
Company |
0.06%
|
12,303
|
$19,685 | — | 31 Dec 2025 | |
| Portfolio Strategies, Inc. |
13F
|
Company |
0.06%
|
12,178
|
$19,485 | — | 31 Dec 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.06%
|
12,079
|
$19,326 | — | 31 Dec 2025 | |
| Javier Rodriguez |
3/4/5
|
Chief Legal Officer, Senior Vice President and Corporate Secretary |
—
mixed-class rows
|
8,985
mixed-class rows
|
$10,705 | — | 14 Mar 2026 | |
| Richard I. Steinhart |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
6,892
mixed-class rows
|
$10,369 | — | 14 Mar 2026 |
Recent Insider Transactions by Companies or Individuals for BioXcel Therapeutics, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Ph.D. Vimal Mehta | BTAI | Common Stock | Options Exercise | 1.04% | 219 | 21,259 | 15 Mar 2026 | Direct | ||
| Ph.D. Vimal Mehta | BTAI | Restricted Stock Units | Options Exercise | -12.5% | -219 | 1,532 | 15 Mar 2026 | Direct | ||
| Richard I. Steinhart | BTAI | Common Stock | Options Exercise | 0.53% | 35 | 6,645 | 15 Mar 2026 | Direct | ||
| Richard I. Steinhart | BTAI | Restricted Stock Units | Options Exercise | -12.4% | -35 | 247 | 15 Mar 2026 | Direct | ||
| Javier Rodriguez | BTAI | Common Stock | Options Exercise | 0.51% | 35 | 6,863 | 15 Mar 2026 | Direct | ||
| Javier Rodriguez | BTAI | Restricted Stock Units | Options Exercise | -12.4% | -35 | 247 | 15 Mar 2026 | Direct | ||
| Ph.D Frank Yocca | BTAI | Common Stock | Options Exercise | 0.54% | 35 | 6,520 | 15 Mar 2026 | Direct | ||
| Ph.D Frank Yocca | BTAI | Restricted Stock Units | Options Exercise | -12.4% | -35 | 247 | 15 Mar 2026 | Direct | ||
| Ph.D. Vimal Mehta | BTAI | Common Stock | Options Exercise | 0.79% | 164 | 21,040 | 14 Mar 2026 | Direct | ||
| Ph.D. Vimal Mehta | BTAI | Restricted Stock Units | Options Exercise | -25.2% | -164 | 488 | 14 Mar 2026 | Direct | ||
| Richard I. Steinhart | BTAI | Common Stock | Options Exercise | 0.5% | 33 | 6,610 | 14 Mar 2026 | Direct | ||
| Richard I. Steinhart | BTAI | Restricted Stock Units | Options Exercise | -25.4% | -33 | 97 | 14 Mar 2026 | Direct | ||
| Javier Rodriguez | BTAI | Common Stock | Options Exercise | 0.49% | 33 | 6,828 | 14 Mar 2026 | Direct | ||
| Javier Rodriguez | BTAI | Restricted Stock Units | Options Exercise | -25.4% | -33 | 97 | 14 Mar 2026 | Direct | ||
| Ph.D Frank Yocca | BTAI | Common Stock | Options Exercise | 0.51% | 33 | 6,485 | 14 Mar 2026 | Direct | ||
| Ph.D Frank Yocca | BTAI | Restricted Stock Units | Options Exercise | -25.4% | -33 | 97 | 14 Mar 2026 | Direct | ||
| Sandeep Laumas | BTAI | Stock Option (Right to Buy) | Award | 17,000 | 17,000 | 09 Jan 2026 | Direct | |||
| Rajiv Patni | BTAI | Stock Option (Right to Buy) | Award | 17,000 | 17,000 | 09 Jan 2026 | Direct | |||
| Peter Mueller | BTAI | Stock Option (Right to Buy) | Award | 17,000 | 17,000 | 09 Jan 2026 | Direct | |||
| Michal Votruba | BTAI | Stock Option (Right to Buy) | Award | 17,000 | 17,000 | 09 Jan 2026 | Direct | |||
| Michael Patrick Miller | BTAI | Stock Option (Right to Buy) | Award | 17,000 | 17,000 | 09 Jan 2026 | Direct | |||
| June Bray | BTAI | Stock Option (Right to Buy) | Award | 17,000 | 17,000 | 09 Jan 2026 | Direct | |||
| David J. Mack | BTAI | Stock Option (Right to Buy) | Award | 17,000 | 17,000 | 09 Jan 2026 | Direct | |||
| Ph.D Frank Yocca | BTAI | Restricted Stock Units | Award | 24822.7% | 70,000 | 70,282 | 01 Jan 2026 | Direct | ||
| Richard I. Steinhart | BTAI | Restricted Stock Units | Award | 24822.7% | 70,000 | 70,282 | 01 Jan 2026 | Direct | ||
| Ph.D. Vimal Mehta | BTAI | Restricted Stock Units | Award | 11366.8% | 199,032 | 200,783 | 01 Jan 2026 | Direct | ||
| Javier Rodriguez | BTAI | Restricted Stock Units | Award | 24822.7% | 70,000 | 70,282 | 01 Jan 2026 | Direct | ||
| Ph.D. Vimal Mehta | BTAI | Common Stock | Options Exercise | 1.06% | 219 | 20,876 | 15 Dec 2025 | Direct | ||
| Ph.D. Vimal Mehta | BTAI | Restricted Stock Units | Options Exercise | -11.1% | -219 | 1,751 | 15 Dec 2025 | Direct | ||
| Richard I. Steinhart | BTAI | Common Stock | Options Exercise | 0.54% | 35 | 6,577 | 15 Dec 2025 | Direct | ||
| Richard I. Steinhart | BTAI | Restricted Stock Units | Options Exercise | -11% | -35 | 282 | 15 Dec 2025 | Direct | ||
| Javier Rodriguez | BTAI | Common Stock | Options Exercise | 0.52% | 35 | 6,795 | 15 Dec 2025 | Direct | ||
| Javier Rodriguez | BTAI | Restricted Stock Units | Options Exercise | -11% | -35 | 282 | 15 Dec 2025 | Direct | ||
| Ph.D Frank Yocca | BTAI | Common Stock | Options Exercise | 0.55% | 35 | 6,452 | 15 Dec 2025 | Direct | ||
| Ph.D Frank Yocca | BTAI | Restricted Stock Units | Options Exercise | -11% | -35 | 282 | 15 Dec 2025 | Direct | ||
| Ph.D. Vimal Mehta | BTAI | Common Stock | Options Exercise | 0.8% | 164 | 20,657 | 14 Dec 2025 | Direct | ||
| Ph.D. Vimal Mehta | BTAI | Restricted Stock Units | Options Exercise | -20.1% | -164 | 652 | 14 Dec 2025 | Direct | ||
| Richard I. Steinhart | BTAI | Common Stock | Options Exercise | 0.51% | 33 | 6,542 | 14 Dec 2025 | Direct | ||
| Richard I. Steinhart | BTAI | Restricted Stock Units | Options Exercise | -20.2% | -33 | 130 | 14 Dec 2025 | Direct | ||
| Javier Rodriguez | BTAI | Common Stock | Options Exercise | 0.49% | 33 | 6,760 | 14 Dec 2025 | Direct | ||
| Javier Rodriguez | BTAI | Restricted Stock Units | Options Exercise | -20.2% | -33 | 130 | 14 Dec 2025 | Direct | ||
| Ph.D Frank Yocca | BTAI | Common Stock | Options Exercise | 0.52% | 33 | 6,417 | 14 Dec 2025 | Direct | ||
| Ph.D Frank Yocca | BTAI | Restricted Stock Units | Options Exercise | -20.2% | -33 | 130 | 14 Dec 2025 | Direct | ||
| David J. Mack | BTAI | Common Stock | Options Exercise | 9.1% | 1,694 | 20,317 | 31 Oct 2025 | Direct | ||
| David J. Mack | BTAI | Restricted Stock Units | Options Exercise | -100% | -1,694 | 0 | 31 Oct 2025 | Direct | ||
| David J. Mack | BTAI | Common Stock | Options Exercise | 10% | 1,694 | 18,623 | 30 Sep 2025 | Direct | ||
| David J. Mack | BTAI | Restricted Stock Units | Options Exercise | -50% | -1,694 | 1,694 | 30 Sep 2025 | Direct | ||
| Ph.D. Vimal Mehta | BTAI | Common Stock | Options Exercise | 1.08% | 219 | 20,493 | 15 Sep 2025 | Direct | ||
| Ph.D. Vimal Mehta | BTAI | Restricted Stock Units | Options Exercise | -10% | -219 | 1,970 | 15 Sep 2025 | Direct | ||
| Richard I. Steinhart | BTAI | Common Stock | Options Exercise | 0.54% | 35 | 6,509 | 15 Sep 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.